Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
Perspectives in Public Health
|
June 30, 2016
Early life immune ontogeny - understanding how we build and sustain immunity to infection
David J Dowling
Immunohorizons
|
April 26, 2019
Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants
David J Dowling
The Pediatric Infectious Disease Journal
|
September 10, 2015
Pediatric Vaccine Adjuvants: Components of the Modern Vaccinologist's Toolbox
David J Dowling, Ofer Levy
Trends in Immunology
|
June 2, 2014
Ontogeny of early life immunity
David J Dowling, Ofer Levy
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 5, 2022
A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations
David J Dowling, Ofer Levy
Current Opinion in Pediatrics
|
January 7, 2020
Toward precision adjuvants: optimizing science and safety
Etsuro Nanishi, David J Dowling, Ofer Levy
Frontiers in Immunology
|
March 6, 2020
The TLR5 Agonist Flagellin Shapes Phenotypical and Functional Activation of Lung Mucosal Antigen Presenting Cells in Neonatal Mice
Pankaj Sharma, Ofer Levy, David J Dowling
Nature Communications
|
October 9, 2025
Incorporating meningeal immunity into vaccine development
Manisha Menon, Colin N Haile, David J Dowling
Journal of Immunology (Baltimore, Md. : 1950)
|
November 9, 2025
Deep phenomics of PRR agonist activated human blood
Soumik Barman, Arsh Patel, Aisling Kelly, et al.
Pharmaceutics
|
June 28, 2023
Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations
Branden Lee, Etsuro Nanishi, Ofer Levy, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
Perspectives in Public Health
|
June 30, 2016
Early life immune ontogeny - understanding how we build and sustain immunity to infection
David J Dowling
Immunohorizons
|
April 26, 2019
Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants
David J Dowling
The Pediatric Infectious Disease Journal
|
September 10, 2015
Pediatric Vaccine Adjuvants: Components of the Modern Vaccinologist's Toolbox
David J Dowling, Ofer Levy
Trends in Immunology
|
June 2, 2014
Ontogeny of early life immunity
David J Dowling, Ofer Levy
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 5, 2022
A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations
David J Dowling, Ofer Levy
Current Opinion in Pediatrics
|
January 7, 2020
Toward precision adjuvants: optimizing science and safety
Etsuro Nanishi, David J Dowling, Ofer Levy
Frontiers in Immunology
|
March 6, 2020
The TLR5 Agonist Flagellin Shapes Phenotypical and Functional Activation of Lung Mucosal Antigen Presenting Cells in Neonatal Mice
Pankaj Sharma, Ofer Levy, David J Dowling
Nature Communications
|
October 9, 2025
Incorporating meningeal immunity into vaccine development
Manisha Menon, Colin N Haile, David J Dowling
Journal of Immunology (Baltimore, Md. : 1950)
|
November 9, 2025
Deep phenomics of PRR agonist activated human blood
Soumik Barman, Arsh Patel, Aisling Kelly, et al.
Pharmaceutics
|
June 28, 2023
Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations
Branden Lee, Etsuro Nanishi, Ofer Levy, et al.
Page
of 7